Preparing for the Growth of the Cold Chain

Is Medicare plan switching influenced by initial type of Medicare coverage and cancer history?

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

View the Pharmaceutical Commerce June 2025 issue in an interactive format.

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

Stay updated on the Drug Supply Chain Security Act as pharma stakeholders prepare for upcoming deadlines and improved data traceability.

The Asembia AXS25 Summit strives to explore ways to improve patient outcomes, especially for rare and complex diseases.